{"id":10935,"date":"2026-05-26T16:00:00","date_gmt":"2026-05-26T14:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=38ca21723f9e97eb3b145de45da4b966"},"modified":"2026-05-26T16:00:00","modified_gmt":"2026-05-26T14:00:00","slug":"mevion-medical-systems-and-tam-anh-general-hospital-partner-to-bring-advanced-proton-therapy-to-vietnam","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=10935","title":{"rendered":"Mevion Medical Systems and Tam Anh General Hospital Partner to Bring Advanced Proton Therapy to Vietnam"},"content":{"rendered":"

\nBridging the Gap in Cancer Care with Practical, Accessible, and High-Precision Technology<\/b><\/p><\/a><\/a>

LITTLETON, Mass.--(BUSINESS WIRE)--#MevionFIT<\/a>--Mevion Medical Systems has signed a definitive purchase agreement to bring the MEVION S250-FIT Proton Therapy System\u2122 to Tam Anh General Hospital in Vietnam. This would be the first proton therapy system in Vietnam. This signing reflects a broader shift in cancer care: proton therapy is becoming more practical to deploy, enabling more hospitals to bring advanced treatment closer to the patients who need it. Both the MEVION S250-FIT\u2122 and MEVION S250i Proton Therapy System\u00ae have recently received regulatory approval in Vietnam, marking an important step toward clinical implementation.<\/p>

\nThe introduction of proton therapy at Tam Anh General Hospital marks a turning point for cancer care in Southeast Asia and is facilitated by TD Tech Company, Mevion\u2019s distributor in Vietnam. By establishing this domestic capability, Vietnam joins a growing group of countries expanding access to advanced proton therapy, ensuring that Vietnamese patients have access to world-class treatment within their own borders. The MEVION S250-FIT system at Tam Anh General Hospital is expected to become operational as early as late 2027, upon the inauguration of Tam Anh\u2019s new facility in Phu My Hung, one of Vietnam\u2019s most modern urban areas.<\/p>

\nProton therapy is widely regarded as one of the most advanced forms of radiation treatment available today. Unlike conventional photon (X-ray) radiation therapy, proton beams can precisely deposit the majority of their energy directly within the tumor while minimizing exit dose beyond the target. This level of precision reduces radiation exposure to healthy tissues and helps lessen treatment-related side effects in select clinical scenarios, particularly for complex tumors and pediatric cancers.<\/p>

\nMEVION S250-FIT\u2122: Making Proton Therapy a Reality<\/b><\/p>

\nThe cornerstone of this partnership is the MEVION S250-FIT<\/b>, a breakthrough technology designed to make proton therapy a practical reality for hospitals worldwide. Historically, proton therapy required massive, multi-story facilities and decade-long planning cycles. The FIT\u2122 platform changes this paradigm, enabling advanced care to be deployed with unprecedented ease:<\/p>